109 related articles for article (PubMed ID: 19365286)
1. Economic impact of the BP DownShift Program on blood pressure control among commercial driver license employees.
Greene BL; Miller JD; Brown TM; Harshman RS; Richerson GT; Doyle JJ
J Occup Environ Med; 2009 May; 51(5):542-53. PubMed ID: 19365286
[TBL] [Abstract][Full Text] [Related]
2. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
[TBL] [Abstract][Full Text] [Related]
3. Health and disability costs of depressive illness in a major U.S. corporation.
Druss BG; Rosenheck RA; Sledge WH
Am J Psychiatry; 2000 Aug; 157(8):1274-8. PubMed ID: 10910790
[TBL] [Abstract][Full Text] [Related]
4. Impact of a hypertension management/health promotion program on commercial driver's license employees of a self-insured utility company.
Harshman RS; Richerson GT; Hadker N; Greene BL; Brown TM; Foster TS; Turner BH; Skrepnek SH; Doyle JJ
J Occup Environ Med; 2008 Mar; 50(3):359-65. PubMed ID: 18332786
[TBL] [Abstract][Full Text] [Related]
5. A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costs.
Song X; Huse DM; Williams SA; Borok GM; McDonough K; Ozminkowski RJ
J Occup Environ Med; 2006 Oct; 48(10):1014-22. PubMed ID: 17033501
[TBL] [Abstract][Full Text] [Related]
6. The benefit to cost ratio of work-site blood pressure control programs.
Foote A; Erfurt JC
JAMA; 1991 Mar; 265(10):1283-6. PubMed ID: 1899894
[TBL] [Abstract][Full Text] [Related]
7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
8. Improved blood pressure control among school bus drivers with hypertension.
Doyle J; Severance-Fonte T; Morandi-Matricaria E; Wogen J; Frech-Tamas F
Popul Health Manag; 2010 Apr; 13(2):97-103. PubMed ID: 20415620
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
Murray CJ; Lauer JA; Hutubessy RC; Niessen L; Tomijima N; Rodgers A; Lawes CM; Evans DB
Lancet; 2003 Mar; 361(9359):717-25. PubMed ID: 12620735
[TBL] [Abstract][Full Text] [Related]
10. Does Targeting Higher Health Risk Employees or Increasing Intervention Intensity Yield Savings in a Workplace Wellness Program?
Kapinos KA; Caloyeras JP; Liu H; Mattke S
J Occup Environ Med; 2015 Dec; 57(12):1257-61. PubMed ID: 26641821
[TBL] [Abstract][Full Text] [Related]
11. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
[TBL] [Abstract][Full Text] [Related]
12. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of work-site wellness programs for hypertension control, weight loss, and smoking cessation.
Erfurt JC; Foote A; Heirich MA
J Occup Med; 1991 Sep; 33(9):962-70. PubMed ID: 1744745
[TBL] [Abstract][Full Text] [Related]
14. The Shell Disability Management Program: a five-year evaluation of the impact on absenteeism and return-on-investment.
Wendt JK; Tsai SP; Bhojani FA; Cameron DL
J Occup Environ Med; 2010 May; 52(5):544-50. PubMed ID: 20431409
[TBL] [Abstract][Full Text] [Related]
15. [Workplace Health Management -- sick employees cost you money].
Stork J; Nasterlack M; Tautz A; Letzel S
Dtsch Med Wochenschr; 2013 Nov; 138(48):2484. PubMed ID: 24254353
[No Abstract] [Full Text] [Related]
16. Managing manifest diseases, but not health risks, saved PepsiCo money over seven years.
Caloyeras JP; Liu H; Exum E; Broderick M; Mattke S
Health Aff (Millwood); 2014 Jan; 33(1):124-31. PubMed ID: 24395944
[TBL] [Abstract][Full Text] [Related]
17. Six-year cost trends at PPG industries paralleling the introduction of health promotion programs directed at cardiovascular disease prevention.
Goetzel RZ; Kowlessar NM; Henke R; Benevent R; Tabrizi M; Colombi AM
J Occup Environ Med; 2013 May; 55(5):483-9. PubMed ID: 23618880
[TBL] [Abstract][Full Text] [Related]
18. The impact of the highmark employee wellness programs on 4-year healthcare costs.
Naydeck BL; Pearson JA; Ozminkowski RJ; Day BT; Goetzel RZ
J Occup Environ Med; 2008 Feb; 50(2):146-56. PubMed ID: 18301171
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
Schwander B; Gradl B; Zöllner Y; Lindgren P; Diener HC; Lüders S; Schrader J; Villar FA; Greiner W; Jönsson B
Value Health; 2009 Sep; 12(6):857-71. PubMed ID: 19508663
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.
Page RL; Ghushchyan V; Gifford B; Read RA; Raut M; Crivera C; Naim AB; Damaraju CV; Nair KV
J Occup Environ Med; 2013 Jul; 55(7):761-7. PubMed ID: 23787565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
